Caliper's Revenues Down on Divestitures; Net Loss Drops 33 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported that its first-quarter revenues declined 3 percent, as divestitures and currency effects hit its top line, but increased 11 percent on an organic basis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.